4.1 Article

Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence

期刊

ADDICTION BIOLOGY
卷 22, 期 5, 页码 1366-1377

出版社

WILEY
DOI: 10.1111/adb.12408

关键词

abstinence; acylethanolamides; alcohol use disorder; DSM-IV-TR; oleoylethanolamide; psychiatric comorbidity

资金

  1. Ministerio de Economia y Competitividad and Instituto de Salud Carlos III [PI13/02261]
  2. Instituto de Salud Carlos III and EU-ERDF (Subprograma RETICS Red de Trastornos Adictivos) [RD12/0028/0001]
  3. Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas [PNSD049/2013, PNSD005/2015]
  4. Junta de Andalucia, Plan Andaluz de Investigacion, Desarrollo e Innovacion [PAIDI CTS-433]
  5. Junta de Andalucia-Consejeria de Economia, Innovacion y Ciencia [PI45403]
  6. Junta de Andalucia-Consejeria de Igualdad, Salud y Politicas Sociales [PI-0823-2012, PI-0228-2013]
  7. Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER/EU-ERDF) [CP14/00212, CP12/03109, CP14/00173]
  8. ISC-III [CM13/00115, CD12/00455]

向作者/读者索取更多资源

Acylethanolamides are a family of endogenous lipid mediators that are involved in physiological and behavioral processes associated with addiction. Recently, oleoylethanolamide (OEA) has been reported to reduce alcohol intake and relapse in rodents but the contribution of OEA and other acylethanolamides in alcohol addiction in humans is unknown. The present study is aimed to characterize the plasma acylethanolamides in alcohol dependence. Seventy-nine abstinent alcohol-dependent subjects (27 women) recruited from outpatienttreatment programs and age-/sex-/bodymass-matched healthy volunteers (28 women) were clinically assessed with the diagnostic interview PRISM according to the DSM-IV-TR after blood extraction for quantification of acylethanolamide concentrations in the plasma. Our results indicate that all acylethanolamides were significantly increased in alcohol-dependent patients compared with control subjects (p < 0.001). A logistic model based on these acylethanolamides was developed to distinguish alcohol-dependent patients from controls and included OEA, arachidonoylethanolamide (AEA) and docosatetraenoylethanolamide (DEA), providing a high discriminatory power according to area under the curve [AUC = 0.92 (95% CI: 0.87-0.96), p < 0.001]. Additionally, we found a significant effect of the duration of alcohol abstinence on the concentrations of OEA, AEA and DEA using a regression model (p < 0.05, p < 0.01 and p < 0.001, respectively), which was confirmed by a negative correlation (rho = -0.31, -0.40 and -0.44, respectively). However, acylethanolamides were not influenced by the addiction alcohol severity, duration of problematic alcohol use or diagnosis of psychiatric comorbidity. Our results support the preclinical studies and suggest that OEA, AEA and DEA are altered in alcohol-dependence during abstinence and that might act as potential markers for predicting length of alcohol abstinence.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据